{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:43:16Z","timestamp":1792784596671,"version":"4.5.0"},"reference-count":26,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M731484"],"award-info":[{"award-number":["2023M731484"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024YQ073"],"award-info":[{"award-number":["ZR2024YQ073"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collaborative Academic Innovation Project of Shandong Cancer Hospital","award":["TS009"],"award-info":[{"award-number":["TS009"]}],"id":[{"id":"https:\/\/ror.org\/01413r497","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["82203218"],"award-info":[{"award-number":["82203218"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>B7\u2212H3 is widely expressed in multiple solid tumors but shows minimal expression in normal tissues, making it an ideal target for molecular imaging; however, its systematic investigation remains limited. In this study, we utilized the clinically investigated B7\u2212H3-targeted antibody\u2212drug conjugate (ADC) HS-20093 to develop and evaluate a novel immuno-positron emission tomography (immuno-PET) tracer, [89Zr]Zr-DFO-HS-20093, for accurate imaging of B7\u2212H3 expression in lung cancer and triple-negative breast cancer models. [89Zr]Zr-DFO-HS-20093 was synthesized with high radiochemical purity (98.2 \u00b1 0.6%). Cellular uptake assays revealed significantly higher tracer uptake in A549 cells than in 4T1 cells at 1, 2, and 4 h (all P &amp;lt; 0.0001), which was markedly reduced by blocking with excess unlabeled antibody. Immunofluorescence revealed predominant membrane localization of B7\u2212H3 in 4T1 cells, whereas A549 cells exhibited pronounced intracellular distribution, suggesting enhanced internalization. In tumor-bearing mice, [89Zr]Zr-DFO-HS-20093 positron emission tomography (PET)\/CT enabled clear tumor visualization, with peak uptake at 24 h post-injection in both A549 and 4T1 xenografts (9.63 \u00b1 1.97 and 7.15 \u00b1 3.14 \u03bcCi\/mL, respectively), supporting its potential for tumor imaging. Ex vivo biodistribution data corroborated the PET findings, showing significantly higher tracer uptake in A549 tumors (5.01 \u00b1 1.19 % ID\/g) than in blocked tumors (2.89 \u00b1 0.43 % ID\/g) and 4T1 tumors (1.89 \u00b1 0.47 % ID\/g) (P = 0.034 and P = 0.003, respectively). Immunohistochemical analysis of A549 xenografts showed strong B7\u2212H3 expression (3+), whereas 4T1 tumors exhibited lower expression levels (1\u22122+), further confirming that B7\u2212H3 expression patterns were consistent with the imaging results. [89Zr]Zr-DFO-HS-20093 enables sensitive immuno-PET imaging of B7\u2212H3 and reveals tumor-type-dependent differences in B7\u2212H3 expression and intracellular behavior.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00454","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:01:45Z","timestamp":1790179305000},"page":"4884-4892","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical Evaluation of B7\u2212H3-Targeted ADC-Based Molecular Imaging in Lung and Triple-Negative Breast Cancer"],"prefix":"10.1021","volume":"23","author":[{"given":"Jiayu","family":"Sui","sequence":"first","affiliation":[{"name":"Shandong Second Medical University , , , ,","place":["Weifang, Shandong, China, 261053"]},{"name":"Shandong First Medical University and Shandong Academy of Medical Sciences , , , ,","place":["Jinan, Shandong, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Qin","sequence":"additional","affiliation":[{"name":"Shandong First Medical University and Shandong Academy of Medical Sciences , , , ,","place":["Jinan, Shandong, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Saladin","sequence":"additional","affiliation":[{"name":"University of Wisconsin\u2212Madison , , , ,","place":["Madison, Wisconsin, United States, 53706"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"Barnhart","sequence":"additional","affiliation":[{"name":"University of Wisconsin\u2212Madison , , , ,","place":["Madison, Wisconsin, United States, 53792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3399-7228","authenticated-orcid":true,"given":"Jonathan W.","family":"Engle","sequence":"additional","affiliation":[{"name":"University of Wisconsin\u2212Madison , , , ,","place":["Madison, Wisconsin, United States, 53792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Hu","sequence":"additional","affiliation":[{"name":"Shandong First Medical University and Shandong Academy of Medical Sciences , , , ,","place":["Jinan, Shandong, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University , , , ,","place":["Weifang, Shandong, China, 261053"]},{"name":"Shandong First Medical University and Shandong Academy of Medical Sciences , , , ,","place":["Jinan, Shandong, China, 250117"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4641-0833","authenticated-orcid":true,"given":"Weibo","family":"Cai","sequence":"additional","affiliation":[{"name":"University of Wisconsin\u2212Madison , , , ,","place":["Madison, Wisconsin, United States, 53792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-9915","authenticated-orcid":true,"given":"Yuchun","family":"Wei","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University , , , ,","place":["Weifang, Shandong, China, 261053"]},{"name":"Shandong First Medical University and Shandong Academy of Medical Sciences , , , ,","place":["Jinan, Shandong, China, 250117"]},{"name":"University of Wisconsin\u2212Madison , , , ,","place":["Madison, Wisconsin, United States, 53792"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"3","key":"2026100509320550700_cit1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca-Cancer J. Clin."},{"issue":"1","key":"2026100509320550700_cit2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12935-025-03734-w","article-title":"Intratumoral heterogeneity and drug resistance in cancer","volume":"25","author":"Fu","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"12","key":"2026100509320550700_cit3","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/biom12121744","article-title":"Evaluation of B7-H3 Targeted Immunotherapy in a 3D Organoid Model of Craniopharyngioma","volume":"12","author":"Tang","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"2026100509320550700_cit4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ymthe.2023.02.010","article-title":"An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers","volume":"31","author":"Zekri","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"2026100509320550700_cit5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12894-022-01044-1","article-title":"Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer","volume":"22","author":"Mahmoud","year":"2022","journal-title":"BMC Urol."},{"issue":"10","key":"2026100509320550700_cit6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41419-020-03041-4","article-title":"B7-H3 regulates KIF15-activated ERK1\/2 pathway and contributes to radioresistance in colorectal cancer","volume":"11","author":"Ma","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"2026100509320550700_cit7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat. Immunol."},{"issue":"9","key":"2026100509320550700_cit8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni967","article-title":"The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses","volume":"4","author":"Suh","year":"2003","journal-title":"Nat. Immunol."},{"issue":"31","key":"2026100509320550700_cit9","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1200\/jco.2012.42.4887","article-title":"Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology","volume":"30","author":"Knowles","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"2026100509320550700_cit10","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1039\/c7cs00014f","article-title":"The chemistry of PET imaging with zirconium-89","volume":"47","author":"Dilworth","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"2026100509320550700_cit11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.mct-23-0465","article-title":"89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"2026100509320550700_cit12","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.7150\/thno.32883","article-title":"Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model","volume":"9","author":"Kristensen","year":"2019","journal-title":"Theranostics"},{"issue":"8","key":"2026100509320550700_cit13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jjco\/hyae075","article-title":"Evaluation of PET\/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP)","volume":"54","author":"Nakaigawa","year":"2024","journal-title":"Jpn. J. Clin. Oncol."},{"key":"2026100509320550700_cit14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ccell.2026.02.006","article-title":"HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a\/b trial","volume":"44","author":"Duan","year":"2026","journal-title":"Cancer Cell"},{"issue":"8","key":"2026100509320550700_cit15","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00259-018-3941-3","article-title":"ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab","volume":"45","author":"Kang","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026100509320550700_cit16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lungcan.2016.11.013","article-title":"Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis","volume":"103","author":"Inamura","year":"2017","journal-title":"Lung Cancer"},{"key":"2026100509320550700_cit17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejca.2020.03.033","article-title":"Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer","volume":"133","author":"Yim","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"2026100509320550700_cit18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010924","article-title":"Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer","volume":"13","author":"Jiang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"2026100509320550700_cit19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10637-023-01353-8","article-title":"Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments","volume":"41","author":"Omori","year":"2023","journal-title":"Invest. New Drugs"},{"issue":"7","key":"2026100509320550700_cit20","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.3390\/ijms25073976","article-title":"B7-H3 Expression in Breast Cancer and Brain Metastasis","volume":"25","author":"Joshi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"2026100509320550700_cit21","first-page":"225","article-title":"Pharmacokinetics and biodistribution of genetically-engineered antibodies","volume":"42","author":"Colcher","year":"1998","journal-title":"Q. J. Nucl. Med."},{"key":"2026100509320550700_cit22","doi-asserted-by":"publisher","first-page":"109294","DOI":"10.1016\/j.apradiso.2020.109294","article-title":"Absolute standardisation and determination of the half-life and gamma emission intensities of 89Zr","volume":"166","author":"Fenwick","year":"2020","journal-title":"Appl. Radiat. Isot."},{"issue":"1","key":"2026100509320550700_cit23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nucmedbio.2012.08.004","article-title":"PET imaging with 89Zr: from radiochemistry to the clinic","volume":"40","author":"Deri","year":"2013","journal-title":"Nucl. Med. Biol."},{"issue":"15","key":"2026100509320550700_cit24","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.7150\/thno.25575","article-title":"Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a","volume":"8","author":"Burvenich","year":"2018","journal-title":"Theranostics"},{"issue":"11","key":"2026100509320550700_cit25","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.7150\/thno.125878","article-title":"Integrated radio-theranostics using a [89Zr]Zr-\/[177Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer","volume":"16","author":"Qiu","year":"2026","journal-title":"Theranostics"},{"issue":"6","key":"2026100509320550700_cit26","doi-asserted-by":"publisher","DOI":"10.1172\/jci186388","article-title":"A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies","volume":"135","author":"Xia","year":"2025","journal-title":"J. Clin. Invest."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00454","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4884\/68622880\/mp6c00454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4884\/68622880\/mp6c00454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:14Z","timestamp":1791208154000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/4884\/5436730\/Preclinical-Evaluation-of-B7-H3-Targeted-ADC-Based"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,23]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00454","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}